DM Intelligence are racing against time to screen drugs target pneumonia caused by COVID-19. Based on the high-resolution crystal structure of Mpro of the novel coronavirus, DM Intelligence has selected some dozens of marketed drugs which may have potential therapeutic effects against novel coronavirus. Consult the tables below for partial information.